株式会社レボルカ （RevolKa）は最先端バイオ製品のコアとなるタンパク質を人工知能で育て進化させ提供することにより世界の人々の「健康」と「豊かさ」に貢献します。
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 30.08.2024 | RevolKa Closes US$1.7M Series A Extension Funding | RevolKa, a Tokyo, Japan-based biotech company advancing an AI-driven protein engineering technology platform, raised US$0.7M and completed a US$1.7M in Series A funding.
D3 co-led the Series A extension round along with DEEPCORE.
The compan... |
| - | RevolKa | “Revolka Co., Ltd. is developing biopharmaceuticals using "aiProtein technology" which combines protein engineering and machine learning by AI in Bunkyo-ku, Tokyo. We contribute to the health and affluence of people around the wor... |
Reviews 0